首页> 美国卫生研究院文献>other >Umbilical cord and bone marrow mesenchymal stem cell seeding on macroporous calcium phosphate for bone regeneration in rat cranial defects
【2h】

Umbilical cord and bone marrow mesenchymal stem cell seeding on macroporous calcium phosphate for bone regeneration in rat cranial defects

机译:脐带和骨髓间充质干细胞在大孔磷酸钙上的植入可促进大鼠颅骨缺损的骨再生

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Human umbilical cord mesenchymal stem cells (hUCMSCs) are inexhaustible and can be harvested at a low cost without an invasive procedure. However, there has been no report on comparing hUCMSCs with human bone marrow MSCs (hBMSCs) for bone regeneration in vivo. The aim of this study was to investigate hUCMSC and hBMSC seeding on macroporous calcium phosphate cement (CPC), and to compare their bone regeneration in critical-sized cranial defects in rats. Cell attachment, osteogenic differentiation and mineral synthesis on RGD-modified macroporous CPC were investigated in vitro. Scaffolds with cells were implanted in 8-mm defects of athymic rats. Bone regeneration was investigated via micro-CT and histological analysis at 4, 12, and 24 weeks. Three groups were tested: CPC with hUCMSCs, CPC with hBMSCs, and CPC control without cells. Percentage of live cells and cell density on CPC in vitro were similarly good for hUCMSCs and hBMSCs. Both cells had high osteogenic expressions of alkaline phosphatase, osteocalcin, collagen I, and Runx2. Bone mineral density and trabecular thickness in hUCMSC and hBMSC groups in vivo were greater than those of CPC control group. New bone amount for hUCMSC-CPC and hBMSC-CPC constructs was increased by 57% and 88%, respectively, while blood vessel density was increased by 15% and 20%, than CPC control group at 24 weeks. hUCMSC-CPC and hBMSC-CPC groups generally had statistically similar bone mineral density, new bone amount and vessel density. In conclusion, hUCMSCs seeded on CPC were shown to match the bone regeneration efficacy of hBMSCs in vivo for the first time. Both hUCMSC-CPC and hBMSC-CPC constructs generated much more new bone and blood vessels than CPC without cells. Macroporous RGD-grafted CPC with stem cell seeding is promising for craniofacial and orthopedic repairs.
机译:人脐带间充质干细胞(hUCMSCs)取之不尽,用之不费钱钱就能以低廉的价格收获它。然而,还没有关于将hUCMSC与人骨髓MSC(hBMSC)进行体内骨再生的比较的报道。本研究的目的是研究在大孔磷酸钙水泥(CPC)上植入hUCMSC和hBMSC,并比较它们在大鼠临界大小颅骨缺损中的骨再生。体外研究了RGD修饰的大孔CPC上的细胞附着,成骨分化和矿物质合成。将具有细胞的支架植入无胸腺大鼠的8毫米缺损中。在第4、12和24周通过显微CT和组织学分析研究了骨再生。测试了三组:具有hUCMSC的CPC,具有hBMSC的CPC和无细胞的CPC对照。对于hUCMSCs和hBMSCs,活细胞的百分比和体外CPC上的细胞密度相似。两种细胞均具有高碱性磷酸酶,骨钙素,胶原蛋白I和Runx2的成骨表达。体内hUCMSC和hBMSC组的骨矿物质密度和小梁厚度均大于CPC对照组。在24周时,与CPC对照组相比,hUCMSC-CPC和hBMSC-CPC构建体的新骨量分别增加了57%和88%,而血管密度增加了15%和20%。 hUCMSC-CPC和hBMSC-CPC组在统计学上通常具有相似的骨矿物质密度,新骨量和血管密度。总之,首次证明了在CPC上接种的hUCMSC与hBMSC的体内骨再生功效相匹配。与没有细胞的CPC相比,hUCMSC-CPC和hBMSC-CPC构造都产生了更多的新骨骼和血管。带有干细胞播种的大孔RGD移植CPC有望用于颅面和骨科修复。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号